Auro-Olmesartan Hctz 25 mg (Hydrochlorothiazide TABLET) 25 MG

AURO-OLMESARTAN HCTZ 25 MG tablets combine olmesartan and hydrochlorothiazide for blood pressure management. This medication is designed to help regulate hypertension and support cardiovascular health.

Strength

25 MG

Pack Size

28/30/100/1000

Manufacturer / TM Owner

AURO PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AURO-OLMESARTAN HCTZ 25 MG tablets are commonly used to manage high blood pressure. The combination of olmesartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual-action therapy to control hypertension effectively.

Side Effects

Common effects of AURO-OLMESARTAN HCTZ 25 MG tablets may include dizziness, fatigue, and mild nausea. Some users might experience changes in electrolyte levels due to the diuretic component. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

AURO-OLMESARTAN HCTZ 25 MG tablets should be handled with care, especially for individuals with kidney or liver conditions. Regular monitoring of blood pressure and electrolyte levels is advisable. Avoid sudden changes in dosage without medical supervision.

Avoid Interactions

AURO-OLMESARTAN HCTZ 25 MG tablets may interact with certain medications, including other blood pressure drugs, NSAIDs, and lithium. Alcohol consumption should be moderated, as it can enhance the effects of the medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

AURO-OLMESARTAN HCTZ 25 MG tablets are used to manage high blood pressure by combining olmesartan and hydrochlorothiazide.

AURO-OLMESARTAN HCTZ 25 MG tablets are typically taken orally, as directed by a healthcare provider.

Common side effects may include dizziness, fatigue, and mild nausea.

AURO-OLMESARTAN HCTZ 25 MG may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Long-term use of AURO-OLMESARTAN HCTZ 25 MG should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.